可必特雾化吸入对慢性阻塞性肺疾病急性加重期的治疗作用

目的 采用随机对照比较可必特雾化吸入在慢性阻塞性肺疾病(COPD)急性加重期的治疗作用.方法 88例患者随机分为2组,除常规给予抗生素、必漱平、氨茶碱等治疗外,治疗组加可必特1 ml雾化吸入,每日2次.结果 2组治疗前症状、体征无差异性,治疗后第1天、第3天在症状、体征消失率以及重症病例减少率差异有显著性(P＜0.05).结论 可必特进一种有效的支气管扩张剂,对COPD急性加重期的临床症状及体征的缓解起着重要作用.

Effects of combivent inhale on acute exacerbations of chronic obstructive pulmonary disease

Objective To investigate the therapeutic effects of combivent inhale on acute exacerbations of chronic obstructive pulmonary disease.Methods 88 patients with COPD were randomly divided into two groups.The basic therapy for the two groups were antibiotic,bisolven,aminophyline,and the treatment group was given 1 ml combivent inhalation two times every day.Results There were no difference in symptom and sign between the two groups before therapy.But there were significant difference in disappearance rate of symptom and sign and decrease rate of severe cases on the first day and the third day between the two groups after therapy(P<0.0).Conclusion As an effective bronchodilator agent,combivent plays an important role in relieving the symptom and sign on acute exacerbations of chronic obstructive pulmonary disease.